BNL puts spike to 52-week high as earnings arrive tomorrow
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
BNL reports on October 29. The put/call ratio hit 0.40 on Tuesday, a 52-week high and 2.9 standard deviations above its 20-day average of 0.15. Short interest jumped 16.1% in one week to 11.0% of free float, the highest level since late September. Both moved together, and in the same direction, just 24 hours before the print.
Puts at a one-year extreme
The PCR reading of 0.40 is not a mild wobble. For most of the past year BNL traded with a PCR below 0.15, a stock that options traders largely left alone. The jump to 0.40, matching the previous 52-week high set the day before on October 26, represents a wholesale shift in how traders are using the options market on this name. That reading arrived alongside a stock down 3.3% over the past week, against a median decline of 0.9% for its closest peers including EPRT and WPC.
Short interest rises to a month-high
The 11.0% short interest figure is material for a diversified REIT. The month-long picture is more nuanced: SI peaked near 14% at the end of September, fell sharply through early October, then reversed sharply this week. The FINRA fortnightly figure, settled at October 15, put short shares at 20.77 million with 9.96 days to cover. The borrow market is not strained by this demand. Availability stands at 602%, meaning roughly six shares remain available in the lending pool for every one currently borrowed. Cost to borrow is 0.38%, down 10% from a week ago. Short sellers are not paying up to add exposure.
Retail attention picks up
The alt data layer adds a separate signal. ORTEX page traffic and English Wikipedia views for BNL, combined into a z-score against the stock's own 90-day history, reached 2.8 standard deviations above average as of October 25. This measures attention, not positioning. It is not a leading indicator of revenue or earnings.
Analyst consensus sits well above the current price
The mean analyst price target is $23.10 against a close of $17.18, a gap of 34.5%. The most recent rating change, from Truist Securities on October 2, was an upgrade to Buy despite a target cut to $21.00. The last two earnings prints, July 29 and July 30, both produced negative one-day and five-day reactions, the stock falling more than 3% and 4% respectively after each.
What to watch
The October 29 print is the single near-term event that resolves the current positioning. The ORTEX short score reached 61.8 on October 27, up from 57.3 on October 23, a four-point move in four sessions that reflects the combined pressure from rising SI and the options shift.
Data summary
- Short interest: 11.0% of free float, up 16.1% in one week
- PCR: 0.40 on October 27, a 52-week high, z-score of 2.9
- Borrow availability: 602%, cost to borrow 0.38%
- Stock: $17.18, down 3.3% on the week
- Mean analyst target: $23.10; most recent action: Truist upgrade to Buy, target $21.00
- Retail attention z-score: 2.8 vs own 90-day average (as of October 25)
- Earnings: October 29
Stocks in this article
See the live data behind this article on ORTEX.
Open BNL on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 20:27
- Data as of
- 28 Oct 2026, 20:23
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.